These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 17143800

  • 21. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB.
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [Abstract] [Full Text] [Related]

  • 22. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 23. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T.
    Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136
    [Abstract] [Full Text] [Related]

  • 24. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.
    Neurosurgery; 2009 Sep 01; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [Abstract] [Full Text] [Related]

  • 25. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS.
    J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244
    [Abstract] [Full Text] [Related]

  • 26. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
    Belyanskaya LL, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon HU, Stahel R, Zangemeister-Wittke U.
    Lung Cancer; 2008 Jun 15; 60(3):355-65. PubMed ID: 18093694
    [Abstract] [Full Text] [Related]

  • 27. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 28. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.
    Pespeni MH, Hodnett M, Abayasiriwardana KS, Roux J, Howard M, Broaddus VC, Pittet JF.
    Cancer Res; 2007 Mar 15; 67(6):2865-71. PubMed ID: 17363610
    [Abstract] [Full Text] [Related]

  • 29. A critical role of PUMA in maintenance of genomic integrity of murine spermatogonial stem cell precursors after genotoxic stress.
    Forand A, Bernardino-Sgherri J.
    Cell Res; 2009 Aug 15; 19(8):1018-30. PubMed ID: 19417777
    [Abstract] [Full Text] [Related]

  • 30. [Study on the potential mechanisms of leukemia cell resistance to TRAIL-induced apoptosis].
    Hao JH, Hao XS, Yu M, Shi YR, Yang Y.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun 15; 27(6):379-82. PubMed ID: 17147226
    [Abstract] [Full Text] [Related]

  • 31. The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway.
    Ayed-Boussema I, Bouaziz C, Rjiba K, Valenti K, Laporte F, Bacha H, Hassen W.
    Toxicol In Vitro; 2008 Oct 15; 22(7):1671-80. PubMed ID: 18662769
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cells.
    Johnson AL, Ratajczak C, Haugen MJ, Liu HK, Woods DC.
    Reproduction; 2007 Mar 15; 133(3):609-16. PubMed ID: 17379655
    [Abstract] [Full Text] [Related]

  • 33. TRAIL-related neurotoxicity implies interaction with the Wnt pathway in human neuronal cells in vitro.
    Cantarella G, Di Benedetto G, Pezzino S, Risuglia N, Bernardini R.
    J Neurochem; 2008 Jun 15; 105(5):1915-23. PubMed ID: 18266928
    [Abstract] [Full Text] [Related]

  • 34. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui Y, Li Q.
    Med Oncol; 2015 Apr 15; 32(4):133. PubMed ID: 25796504
    [Abstract] [Full Text] [Related]

  • 35. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E, Vodjgani M, Massoud A, Keyhani A, Rajab A, Shafaghi B, Gheflati Z, Aboufazeli T.
    Iran J Immunol; 2007 Dec 15; 4(4):197-205. PubMed ID: 18057577
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death.
    Woods DC, Liu HK, Nishi Y, Yanase T, Johnson AL.
    Cancer Lett; 2008 Feb 18; 260(1-2):20-7. PubMed ID: 18031928
    [Abstract] [Full Text] [Related]

  • 37. Valproic acid sensitizes K562 erythroleukemia cells to TRAIL/Apo2L-induced apoptosis.
    Iacomino G, Medici MC, Russo GL.
    Anticancer Res; 2008 Feb 18; 28(2A):855-64. PubMed ID: 18507029
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
    Sivaprasad U, Shankar E, Basu A.
    Cell Death Differ; 2007 Apr 18; 14(4):851-60. PubMed ID: 17186022
    [Abstract] [Full Text] [Related]

  • 40. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.
    Gynecol Oncol; 2007 May 18; 105(2):481-92. PubMed ID: 17292950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.